ecosystem / people / fazila-seker
Dr. Fazila Seker on the TechTO stage

Dr. Fazila Seker

CEO, Insight Medbotics

MedTechOn TechTO stages since 2025

PhD chemist turned medtech founder. Fazila Seker began at GE running innovation programs, then founded MOLLI Surgical, which simplified breast cancer surgery and was acquired by Stryker. Now CEO of Insight Medbotics, she leads the first FDA-cleared robot for use with MRI, refocused on precision prostate cancer care.

On the TechTO stage ×1

First seen on a TechTO stage in 2025. Every TechTO talk is searchable — ask the archive about Dr. Fazila

In their words

The first step is to fall in love with your customer.

TechTO, Sep 2025 · watch at 01:30

When you really think about it, risk is just the quality of the opportunity and the quality of the people.

TechTO, Sep 2025 · watch at 03:00

The act of creating something new is messy and your only tool is communication. So it's got to be simple and it's got to be consistent.

TechTO, Sep 2025 · watch at 04:05
A few quotes can’t cover everything Dr. Fazila said on the TechTO stage. 1,570 talks are searchable.Ask about Dr. Fazila

Around the web ×2

Quick answers

What does Insight Medbotics do?

It makes a robot compatible with the MRI scanner environment — the first and only robot FDA cleared for use with MRI (July 2023). After discovery calls with about 30 physicians, the team pivoted from breast biopsy to giving urologists MRI precision for prostate cancer care, replacing the guesswork of traditional ultrasound methods.

What happened with her first startup, MOLLI Surgical?

Founded in 2018 to make precision surgery simpler, starting with breast cancer, it grew from two people to over 50 across the US and Canada in under four years, earned simultaneous Health Canada approval and FDA clearance, and was recently sold to Stryker.

Does she launch in Canada or the US first?

Insight Medbotics is US-first: MRI access in Canada is so constrained that scans happen at 3 a.m. on a Sunday, which doesn't happen in the US. She defaults to making a case in the largest market — the US next door, then Europe and APAC — though Canadian private practice may open opportunity.

Suggest an editThis is you? Claim this profileAsk to be removed
Maintained by TechTO · facts sourced and dated · last reviewed Jul 13, 2026